Quick answer
Foundayo is an oral GLP-1 pill (orforglipron) and Mounjaro is a weekly tirzepatide injection that acts on two gut hormone receptors. Both can support appetite control and weight loss when used under medical supervision with lifestyle care. Neither is universally better. The right choice depends on your health, your preferences and your specialist’s assessment.
If you are weighing up a daily pill against a weekly injection, you are really asking two questions at once: which one suits my body, and which one suits my life. This is a balanced, side-by-side look at Foundayo and Mounjaro to help you have a clear conversation with your doctor. It is not a ranking, because the better option is the one that fits you.
What is Foundayo (orforglipron)?
Foundayo is an oral GLP-1 medication. Its active ingredient is orforglipron. It was approved by the US FDA in April 2026 and is available at Endocare in Dubai and Abu Dhabi through licensed pharmacies. Being a pill, it is taken once daily, with or without food, at any time of day, which many people find simple to build into a routine. In its ATTAIN-1 trial, orforglipron produced an average weight loss of about 12% of total body weight, with some patients losing up to 15%.
What is Mounjaro (tirzepatide)?
Mounjaro is a once-weekly injection. Its active ingredient is tirzepatide. It is a dual receptor agonist, meaning it acts on two gut hormone pathways at once, GLP-1 and GIP. In its SURMOUNT-1 trial at the 15 mg dose, tirzepatide produced an average weight loss of about 20% of total body weight over the study period. Mounjaro doses range from 2.5 mg up to 15 mg. Your endocrinologist selects the starting dose and increases it in steps at your follow-up appointments.
How they work (mechanism)
Both medicines work largely by influencing appetite and fullness through gut hormone signalling, which helps many people eat less without constant willpower. The main mechanistic difference is reach: Mounjaro (tirzepatide) acts on both the GLP-1 and GIP receptors, while Foundayo is a GLP-1 based oral option. In practice, that dual action is part of why the injection has shown larger average weight loss in trials, though individual results always vary.
Format and dosing: pill vs weekly injection
This is often the deciding factor for everyday life. Foundayo is a tablet taken once a day. Mounjaro is an injection taken once a week using a simple pen, which you can self-administer at home, with the option of having early doses given at the clinic until you feel confident. With both, your specialist sets the starting dose and adjusts it gradually. For Mounjaro, dose decisions are made together with your specialist at the monthly follow-up, in roughly four-week increments, based on your response and tolerance. There is no automatic step-up after four weeks.
Side effects and tolerability
The side-effect profiles of the two medicines are broadly comparable. Both can bring digestive side effects such as nausea, a feeling of fullness, or changes in digestion, reported more often early on or after a dose increase. These can be more pronounced in the first few days at a new dose and usually settle within the first two weeks at that step. Not every patient experiences them. Whichever option you choose, a gradual dose and good nutrition and hydration help keep side effects manageable, and your clinic can adjust the plan or, where appropriate, prescribe additional medication to ease symptoms.
Cost in the UAE
Medication cost and treatment cost are two different things. For [Internal link suggestion: Mounjaro], the medication price is AED 1,734 per month in the UAE. This is the unified price across the country and it is the same at every dose, from 2.5 mg to 15 mg. Foundayo pricing can vary, so it is best confirmed at consultation. On treatment cost, Endocare offers a full Weight-Loss Package at AED 2,990 per month, which includes the medication, unlimited specialist consultations, lifestyle coaching, a body composition analysis at every visit, scheduled labs and free delivery. This is where patients tend to see the best results. There is also a consultation-only option for patients who already work on their lifestyle with their own nutritionist or personal trainer.
Side-by-side comparison
| Feature | Foundayo (orforglipron) | Mounjaro (tirzepatide) |
| Format | Oral pill, once daily | Once-weekly injection |
| How to take it | With or without food, any time of day | Self-injected weekly. First doses can be given in clinic |
| Mechanism | GLP-1 based | Dual GIP and GLP-1 receptor agonist |
| Dosing | 0.8 mg to 17.2 mg once daily | 2.5 mg to 15 mg once weekly |
| Average weight loss in trials (% of body weight) | About 12% on average, up to 15% (ATTAIN-1) | About 20% on average at 15 mg (SURMOUNT-1) |
| Common side effects | Digestive effects possible, usually temporary | Nausea and digestive discomfort, usually temporary |
| UAE access | Prescription only | Prescription only |
| Medication price (UAE) | Varies, confirm at consultation | AED 1,734 per month, unified at every dose |
Who may be better suited to a pill or an injection
There is no fixed rule, and suitability is a clinical decision rather than a self-assessment. That said, some people strongly prefer the convenience of a daily tablet and the absence of injections, while others prefer a once-weekly routine that requires no daily attention. Medical history, how you tolerate the medicine, the weight-loss response you are aiming for, and cost all feed into the decision. Your specialist weighs these together with you.
Can you switch between them?
Switching between GLP-1 options is sometimes appropriate, for example because of tolerability, results, preference or availability. It is not something to do on your own. A switch should be planned and supervised so the timing, the starting dose of the new medicine, and the monitoring are handled safely. If you are considering a change, raise it at a follow-up appointment and your specialist will guide the transition.
How Endocare helps you decide
Choosing between Foundayo and Mounjaro is easier with an endocrinologist-led assessment rather than guesswork. At Endocare, the process starts with a specialist consultation and recent labs, after which your specialist recommends a suitable option and sets the dose. Lifestyle coaching runs alongside the medicine to support nutrition, movement, sleep and stress, and a body composition analysis is included free of charge with every consultation, for every patient, on every visit, so progress and muscle are tracked over time. Both medicines work best as part of this kind of medical weight loss program, not on their own.
Key takeaways
- Foundayo is taken orally. Mounjaro is a once-weekly injection.
- Mounjaro (tirzepatide) acts on GLP-1 and GIP. Foundayo is a GLP-1 based oral option.
- In clinical trials, average weight loss was about 20% of total body weight with Mounjaro and about 12% with Foundayo, though individual results vary.
- Both work best alongside nutrition, movement and coaching.
- Both are prescription only in the UAE and need specialist dosing.
In one line
Foundayo (orforglipron) is an oral GLP-1 medication for weight management. Mounjaro (tirzepatide) is an injectable dual GIP and GLP-1 receptor agonist.
Frequently asked questions
Is Foundayo as effective as Mounjaro?
In their trials, tirzepatide (Mounjaro) produced a higher average weight loss, about 20% of total body weight at the top dose, while orforglipron (Foundayo) produced about 12%, with some patients losing up to 15%. Trial averages are not a personal guarantee, and the best option for you depends on your assessment, tolerability and preferences.
Pill or injection: which should I choose?
The choice depends on what suits you best. Some people prefer a daily tablet with no injections. Others prefer a once-weekly routine. Effectiveness, side-effect tolerance, medical history and cost all matter, and your specialist helps you weigh them.
Can I switch from Mounjaro to Foundayo?
Sometimes, yes, but only under medical supervision. A switch needs the timing, starting dose and monitoring handled by your specialist. Raise it at a follow-up appointment rather than changing on your own.
Are the side effects different?
They are broadly similar. Both can bring digestive effects such as nausea, usually mild and most noticeable early on or after a dose increase, and usually settling within about two weeks. Some patients experience none at all.
Which is cheaper in the UAE?
Mounjaro’s medication price is AED 1,734 per month, the same at every dose. Foundayo pricing varies and is best confirmed at consultation, so a direct comparison is most accurate once your specialist confirms the current figures.
Book a specialist assessment to find the right option
If you are torn between the pill and the injection, a consultation is the fastest way to a clear answer that fits your body and your routine. Endocare’s specialists in Dubai and Abu Dhabi can compare Foundayo and Mounjaro for your situation, recommend a suitable option, and support you with lifestyle coaching throughout. To ask which option may suit you or to book, call our Dubai clinic on +971 4 285 3885, our Abu Dhabi clinic on +971 2 582 6178, or send us a message on WhatsApp.
